Lv1
40 积分 2025-03-09 加入
m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer
16小时前
待确认
YAP/TAZ interacts with RBM39 to confer resistance against indisulam
3天前
已完结
A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation
6天前
已完结
Transport mechanism and pharmacology of the human GlyT1
6天前
已完结
"tumor microenvironment": RNA-binding proteins in the spotlight in colorectal cancer therapy
9天前
已完结
Profiling the Landscape of Drug Resistance Mutations in Neosubstrates to Molecular Glue Degraders
13天前
已完结
Overlaid Transcriptional and Proteome Analyses Identify Mitotic Kinesins as Important Targets of Arylsulfonamide-Mediated RBM39 Degradation
13天前
已完结
Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker
21天前
已关闭
皖公网安备34019202002308
